Matches in Nanopublications for { ?s ?p "[In the majority of classic MPN--polycythemia vera, essential thrombocythemia, and primitive myelofibrosis--driver oncogenic mutations affecting Janus kinase 2 (JAK2) or MPL lead to constitutive activation of cytokine-regulated intracellular signaling pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP423213.RAQPAzTJmDVTqOdkgz4H7cEhpucNu3QRQWTQ8xco9LXqQ130_assertion description "[In the majority of classic MPN--polycythemia vera, essential thrombocythemia, and primitive myelofibrosis--driver oncogenic mutations affecting Janus kinase 2 (JAK2) or MPL lead to constitutive activation of cytokine-regulated intracellular signaling pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423213.RAQPAzTJmDVTqOdkgz4H7cEhpucNu3QRQWTQ8xco9LXqQ130_provenance.
- NP939905.RAX27i9hKAiK5-fXmntUsEoWyyBaOWmHyIXo08LjJOxP0130_assertion description "[In the majority of classic MPN--polycythemia vera, essential thrombocythemia, and primitive myelofibrosis--driver oncogenic mutations affecting Janus kinase 2 (JAK2) or MPL lead to constitutive activation of cytokine-regulated intracellular signaling pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939905.RAX27i9hKAiK5-fXmntUsEoWyyBaOWmHyIXo08LjJOxP0130_provenance.
- NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_assertion description "[In the majority of classic MPN--polycythemia vera, essential thrombocythemia, and primitive myelofibrosis--driver oncogenic mutations affecting Janus kinase 2 (JAK2) or MPL lead to constitutive activation of cytokine-regulated intracellular signaling pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306341.RAuO5fRsaBs6-s5RKGYluZlz8qfJXnwvJHGdfkhFFKZ6c130_provenance.